Disclosures for "A CSF Disease-associated Macrophage Signature Defines Progressive Multiple Sclerosis"
-
The institution of Dr. Bernard-Valnet has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Juvisé. The institution of Dr. Bernard-Valnet has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Bernard-Valnet has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. The institution of Dr. Bernard-Valnet has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. The institution of Dr. Bernard-Valnet has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. The institution of Dr. Bernard-Valnet has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. The institution of Dr. Bernard-Valnet has received research support from Novartis Foundation. The institution of Dr. Bernard-Valnet has received research support from Helmut-Horten Foundation. The institution of Dr. Bernard-Valnet has received research support from Baasch-Medicus Foundation.
-
Mrs. Boersch has nothing to disclose.
-
Frederike Straeten has nothing to disclose.
-
Andreas Schulte-Mecklenbeck has nothing to disclose.
-
The institution of Dr. Heming has received research support from Interdisciplinary Center for Clinical Research. Dr. Heming has received intellectual property interests from a discovery or technology relating to health care. Dr. Heming has received intellectual property interests from a discovery or technology relating to health care.
-
The institution of Dr. Müller-Miny has received research support from Innovative Medical Research Münster .
-
Dr. Wang has nothing to disclose.
-
Dr. Gross has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for DIU Dresden International GmbH. The institution of Dr. Gross has received research support from Biogen, Roche, and Sanofi. Dr. Gross has received intellectual property interests from a discovery or technology relating to health care.
-
Dr. Meyer Zu Horste has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunovant, Argenx, Johnson&Johnson. Dr. Meyer Zu Horste has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen, Argenx, Sanofi. The institution of Dr. Meyer Zu Horste has received research support from Roche. Dr. Meyer Zu Horste has received intellectual property interests from a discovery or technology relating to health care.